GSK189254, a novel H3 receptor antagonist that binds to histamine H3 receptors in Alzheimer's disease brain and improves cognitive performance in preclinical models (Q28574369)
Jump to navigation
Jump to search
scientific journal article
Language | Label | Description | Also known as |
---|---|---|---|
English | GSK189254, a novel H3 receptor antagonist that binds to histamine H3 receptors in Alzheimer's disease brain and improves cognitive performance in preclinical models |
scientific journal article |
Statements
GSK189254, a novel H3 receptor antagonist that binds to histamine H3 receptors in Alzheimer's disease brain and improves cognitive performance in preclinical models (English)
Kim Brackenborough
Jackie Cilia
Barry Crook
Jane Gartlon
Teresa Heslop
Carol Jennings
Abbe Martyn
Sandrine Ociepka
Alison Ray
Joanne Schogger
Eric Southam
Neil Upton
Graham Wadsworth
Trevor White
Jason Witherington
Angela Worby
Andrew D Medhurst
Alan R Atkins
Isabel J Beresford
Michael A Briggs
Andrew R Calver
Jane E Cluderay
John B Davis
Rebecca K Davis
Robert P Davis
Lee A Dawson
Andrew G Foley
M Isabel Gonzalez
Warren D Hirst
Declan N C Jones
Ciaran M Regan
Jennifer C Roberts
Tania O Stean
Brenda K Trail
Jeffrey A Wald
Marie L Woolley
David M Wilson
27 February 2007
321
3
Identifiers
2 references
2 references